Reference
Wang M, et al. Erlotinib combined with bevacizumab and chemotherapy in first line osimertinib-resistant NSCLC patient with leptomeningeal metastasis: A case report. Medicine 100: No. 44, 5 Nov 2021. Available from: URL: http://doi.org/10.1097/MD.0000000000027727
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1897, 45 (2022). https://doi.org/10.1007/s40278-022-11282-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-11282-y